Startseite
arznei-telegramm®  01/2016

NEW ON THE MARKET
Cardiac failure: sacubitril/valsartan (ENTRESTO)

THERAPY FROM A CRITICAL VIEWPOINT
Anticoagulation in atrial fibrillation and advanced renal insufficiency

a-t READER 'S QUESTIONS AND COMMENTS
Modified-release hydrocortisone for adrenal insufficiency?

IN BRIEF
Chlamydia infection: doxycycline versus azithromycin
Oral phenylephrine without benefit in common cold
Surrogate endpoints in oncology

CURRENT ADR NETWORK REPORT
Anosmia with nasal sprays containing glucocorticoids

SIDE EFFECTS
Angioedema with ACE inhibitors plus racecadotril
Intravenous iron preparations: different risks for anaphylaxis
Finasteride and suicidality

e a-t IN THE INTERNET
PCSK-9 inhibitor alirocumab (PRALUENT)
ROCKET AF trial with rivaroxaban is reexamined